Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance

Health Catalyst, Inc. (Nasdaq: HCAT), a prominent provider of data and analytics technology for healthcare organizations, recently announced that its solutions Twistle, Lumeon, and Upfront have achieved HITRUST r2 Certification for robust information security. This certification signifies that these platforms have successfully met rigorous regulatory compliance and industry-defined standards for effective risk management in data protection.

Twistle received its certification in September 2025, while Lumeon achieved it in June 2025. Upfront, notably, earned HITRUST r2 Certification in December 2024 for its Emerald solution hosted on Microsoft Azure, and later obtained a HITRUST e1 Certification for its Ruby solution in August 2025. This accomplishment places Health Catalyst among the elite organizations globally recognized for their commitment to information security.

The HITRUST Assurance Program combines federal and state regulations, standards, and a risk-based framework, which helps address the complexities of security and data protection challenges. Kevin Scharnhorst, Chief Information Security Officer at Health Catalyst, emphasized the company’s dedication to adapting to current and emerging threats while navigating complex compliance landscapes. The achievement of this certification demonstrates the company’s adherence to high standards in data protection.

Vincent Bennekers, Vice President of Quality at HITRUST, noted that a consistent, transparent, and reliable information security assessment is crucial for making informed business decisions, underscoring Health Catalyst's serious approach to compliance and risk management.

These certifications reinforce Health Catalyst's commitment to safeguarding customer data and enhancing trust with healthcare organizations. As a result, Health Catalyst continues to pave the way for data-informed improvements in healthcare, supporting more than 1,100 organizations globally with its innovative technology and services.

Health Catalyst's recent achievement of HITRUST r2 Certification for its platforms—Twistle, Lumeon, and Upfront—positions the company strategically in the competitive healthcare technology market. This certification signifies that Health Catalyst adheres to rigorous standards for information protection and compliance, enhancing its credibility among healthcare organizations facing increasing scrutiny over data security.

Investors should view this development as a positive indicator of Health Catalyst's commitment to maintaining robust security protocols, which is vital in an environment where data breaches are prevalent and regulations are stringent. The HITRUST certification not only reinforces customer trust but also serves as a competitive differentiator, potentially attracting new clients seeking reliable partners for data and analytics solutions.

Health Catalyst operates in a sector that is experiencing rapid growth, driven by the demand for sophisticated analytics to address clinical, operational, and financial challenges in healthcare. With over 1,100 organizations relying on its services, the firm's HITRUST certification establishes a benchmark for quality and security that can drive further client acquisitions and retention.

Moreover, achieving HITRUST certification allows Health Catalyst to address emerging security threats proactively, reducing potential risks associated with data management. As the healthcare industry increasingly shifts towards value-based care, the importance of secure, reliable data systems cannot be overstated; thus, Health Catalyst's offerings are likely to see heightened demand.

In light of this certification, investors should consider increasing their positions in Health Catalyst, particularly as the company continues to innovate and adapt to the evolving healthcare landscape. Long-term growth prospects appear favorable, especially as healthcare organizations prioritize data security and analytics capabilities in their operations. Overall, Health Catalyst's recent accomplishments solidify its role as a leader in data-driven healthcare improvement, making it a compelling investment opportunity.